HDIM
SRNE

Hanson & Doremus Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Hanson & Doremus Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,000
Closed -$1K – 474
2023
Q1 		$1K Buy
+3,000
New +$1K ﹤0.01% 455